Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells

Cancer

Volumn 106, Issue 3, 2006, Pages 599-608

  Alvero, Ayesha B ^a   O'Malley, David ^a   Brown, David ^b   Kelly, Graham ^b   Garg, Manish ^a   Chen, Wei ^a   Rutherford, Thomas ^a   Mor, Gil ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Novogen Limited   (Australia)

Author keywords

Apoptosis; Caspase 2; Chemosensitizer; Ovarian carcinoma; XIAP

Indexed keywords

CARBOPLATIN; CASPASE 2; GEMCITABINE; GLYCOL; ISOFLAVONE DERIVATIVE; PACLITAXEL; PHENOXODIOL; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER PATIENT; CARCINOMA CELL; CHEMOSENSITIVITY; DRUG INDUCED DISEASE; EARLY DIAGNOSIS; EPITHELIUM CELL; HIGH RISK PATIENT; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; OVARY CARCINOMA; PRIORITY JOURNAL; TUMOR MODEL; TUMOR XENOGRAFT;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BLOTTING, WESTERN; CARBOPLATIN; CARCINOMA; CASPASE 2; CASPASES; CELL LINE, TUMOR; DEOXYCYTIDINE; DRUG INTERACTIONS; ENZYME ACTIVATION; FEMALE; HUMANS; ISOFLAVONES; MICE; OVARIAN NEOPLASMS; PACLITAXEL; PROTEASOME ENDOPEPTIDASE COMPLEX; TRANSPLANTATION, HETEROLOGOUS;

EID: 31544466555     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21633     Document Type: Article

References (20)

1. Schmitt CA, Lowe SW. Apoptosis and chemoresistance in transgenic cancer models. J Mol Med. 2002;80:137-146.
2. Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2002;2:277-288.
3. Kamsteeg M, Rutherford T, Sapi E, et al. Phenoxodiol-an isoflavone analog-induces apoptosis in chemoresistant ovarian cancer cells. Oncogene. 2003;22:2611-2620.
4. Constantinou AI, Husband A. Phenoxodiol (2H-1-benzopyran-7-0,1,3-[4- hydroxyphenyl]), a novel isoflavone derivative, inhibits DNA topoisomerase II by stabilizing the cleavable complex. Anticancer Res. 2002;22:2581-2585.
5. Straszewski-Chavez SL, Abrahams VM, Funai EF, Mor G. X-linked inhibitor of apoptosis (XIAP) confers human trophoblast cell resistance to Fas-mediated apoptosis. Mol Hum Reprod. 2004;10:33-41.
6. Behrens BC, Hamilton TC, Masuda H, et al. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res. 1987;47:414-418.
7. Dan HC, Sun M, Kaneko S, et al. Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J Biol Chem. 2004;279:5405-5412.
8. O'Dwyer PJ, Moyer JD, Suffness M, et al. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo. Cancer Res. 1994;54:724-729.
9. Sapi E, Alvero AB, Chen W, et al. Resistance of ovarian carcinoma cells to docetaxel is XIAP dependent and reversible by phenoxodiol. Oncol Res. 2004;14:567-578.
10. Rutherford TD, Makkenchery A, Mor G. Phenoxodiol phase Ib/II study in patients with recurrent ovarian cancer that resistant to second line chemotherapy. J Soc Gynecol Invest. 2004;11:254.
11. Reed JC. Apoptosis-based therapies. Nat Rev Drug Discov. 2002;1:111-121.
12. Li J, Sasaki H, Sheng YL, et al. Apoptosis and chemoresistance in human ovarian cancer: is Xiap a determinant? Biol Signals Recept. 2000;9:122-130.
13. Sasaki H, Sheng Y, Kotsuji F, Tsang BK. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res. 2000;60:5659-5666.
14. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J. 1999;18:5242-5251.
15. Holcik M, Gibson H, Korneluk RG. XIAP: apoptotic brake and promising therapeutic target. Apoptosis. 2001;6:253-261.
16. Srinivasula SM, Gupta S, Datta P, et al. Inhibitor of apoptosis proteins are substrates for the mitochondrial serine protease Omi/HtrA2. J Biol Chem. 2003;278:31469-31472.
17. Johnson DE, Gastman BR, Wieckowski E, et al. Inhibitor of apoptosis protein hILP undergoes caspase-mediated cleavage during T lymphocyte apoptosis. Cancer Res. 2000;60:1818-1823.
18. Adachi M, Katsumura KR, Fujii K, Kobayashi S, Aoki H, Matsuzaki M. Proteasome-dependent decrease in Akt by growth factors in vascular smooth muscle cells. FEBS Lett. 2003;554:77-80.
19. Fraser M, Leung BM, Yan X, Dan HC, Cheng JQ, Tsang BK. p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells. Cancer Res. 2003;63:7081-7088.
20. Aguero MF, Facchinetti MM, Sheleg Z, Senderowicz AM. Phenoxodiol, a novel isoflavone, induces G1 arrest by specific loss in cyclin-dependent kinase 2 activity by p53-independent induction of p21WAF1/CIP1. Cancer Res. 2005; 65:3364-3373.